Dmitry Balyasny’s 1Life Healthcare ONEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-5,318,923
| Closed | -$88.9M | – | 3390 |
|
|
2022
Q4 | $88.9M | Buy |
+5,318,923
| New | +$89.9M | 0.24% | 89 |
|
|
2022
Q3 | – | Sell |
-3,349,036
| Closed | -$52.6M | – | 3407 |
|
|
2022
Q2 | $26.3M | Buy |
3,349,036
+1,276,724
| +62% | +$11M | 0.09% | 335 |
|
|
2022
Q1 | $23M | Buy |
2,072,312
+595,743
| +40% | +$6.67M | 0.07% | 370 |
|
|
2021
Q4 | $25.9M | Buy |
1,476,569
+723,333
| +96% | +$14M | 0.09% | 310 |
|
|
2021
Q3 | $15.3M | Buy |
+753,236
| New | +$19.4M | 0.06% | 416 |
|
|
2021
Q2 | – | Sell |
-92,383
| Closed | -$3.61M | – | 2527 |
|
|
2021
Q1 | $3.61M | Buy |
92,383
+83,608
| +953% | +$3.93M | 0.02% | 820 |
|
|
2020
Q4 | $383K | Sell |
8,775
-152,979
| -95% | -$5.23M | ﹤0.01% | 1159 |
|
|
2020
Q3 | $4.59M | Buy |
161,754
+101,083
| +167% | +$3.19M | 0.03% | 636 |
|
|
2020
Q2 | $2.2M | Buy |
+60,671
| New | +$1.71M | 0.02% | 703 |
|
Dmitry Balyasny's ONEM Position: Q1 2023 in Review
Dmitry Balyasny sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 5,318,923 shares — an estimated $88.9M sold.
Dmitry Balyasny first reported a position in ONEM in Q2 2020 and held it in 9 quarters. The position peaked at $88.9M in Q4 2022. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.
- Dmitry Balyasny reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
- Dmitry Balyasny sold 5,318,923 1Life Healthcare shares in Q1 2023, an estimated $88.9M.
- Dmitry Balyasny first reported a position in 1Life Healthcare in Q2 2020 and held it in 9 quarters.
- Dmitry Balyasny's 1Life Healthcare position peaked at $88.9M in Q4 2022.
- 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.
Based on Balyasny Asset Management's 13F filing for Q1 2023, filed 15 May 2023.